INKEF Capital Appoints Roel Bulthuis as Managing Director to Co-Manage Eur 500m Fund
27 November / 2018
BioClin Therapeutics, Inc.
BioClin Therapeutics, Inc., Completes $50 Million Series B Financing with Addition of New Investors (San Leandro, California, May 9, 2018) BioClin Therapeutics, Inc., a clinical stage drug development company developing a first-in-class anti-FGFR3 (fibroblast growth factor receptor ...May 15 / 2018
Royal Philips today announced that it has acquired NightBalance, a digital health scale-up company based in the Netherlands.May 8 / 2018